A Clinical and Correlative Study of Elotuzumab, Carfilzomib, Lenalidomide, and Dexamethasone (Elo-KRd) for Lenalidomide Refractory Multiple Myeloma in First Relapse

Autor: Bhutani, Manisha *, Foureau, David M. *, Robinson, Myra, Guo, Fei, Fesenkova, Kateryna, Atrash, Shebli, Paul, Barry, Varga, Cindy, Friend, Reed, Pineda-Roman, Mauricio, Rigby, Katherine, Symanowski, James T., Norek, Sarah, Tucker, Mallory R., Druhan, Lawrence J., Voorhees, Peter M., Usmani, Saad Z.
Zdroj: In Clinical Lymphoma, Myeloma and Leukemia July 2023 23(7):535-544
Databáze: ScienceDirect
Externí odkaz: